TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Vistin Pharma AS
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
203,226
|
205,647
|
179,106 |
Financial expenses |
7,968
|
5,722
|
16,416 |
Earnings before taxes |
-2,568
|
26,301
|
26,662 |
Total assets |
285,767
|
236,948
|
158,800 |
Current assets |
111,439
|
91,771
|
56,031 |
Current liabilities |
197,178
|
140,996
|
57,479 |
Equity capital |
38,274
|
40,882
|
20,047 |
- share capital |
71
|
75
|
23 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
13.4%
|
17.3%
|
12.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
-1.3%
|
12.8%
|
14.9% |
Return on assets (ROA) |
1.9%
|
13.5%
|
27.1% |
Current ratio |
56.5%
|
65.1%
|
97.5% |
Return on equity (ROE) |
-6.7%
|
64.3%
|
133.0% |
Change turnover |
8,381
|
16,890
|
17,708 |
Change turnover % |
4%
|
9%
|
11% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.